title: [Conservative treatment of a large retroperitoneal hematoma following extracorporeal shock wave lithotripsy (ESWL): case report and literature review].
abstract: Retroperitoneal and subcapsular renal hematomas, following extracorporeal shock wave lithotripsy (ESWL) occur rarely, but the large number of this treatment performed has to be considered. The knowledge of risk factors, natural history and complications represents a crucial factor in the correct management of these lesions, that generally must be treated conservatively, monitoring clinical parameters and eco-TC diameters of the hematoma. Surgical approache is indicated only in case of haemodinamic instability not responsive to medical therapy and, after 1-2 months, to try to improve renal disfunction due to compression. In this paper we present a case of retroperitoneal hematoma after ESWL and review the literature, so as to define the management of these lesions.
authors.affiliation: Ospedale S. Giovanni Bosco Unità Operativa Complessa di Chirurgia Generale d'Urgenza, ASL Napoli 1. antoniodimuria@tiscali.it
authors.forename: A
authors.initials: A
authors.lastname: Di Muria
authors.forename: V
authors.initials: V
authors.lastname: Formisano
authors.forename: M
authors.initials: M
authors.lastname: Aveta
authors.forename: A
authors.initials: A
authors.lastname: Marano
authors.forename: D
authors.initials: D
authors.lastname: Giglio
mesh_terms: D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001803:Blood Transfusion; D015377:Cilastatin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006406:Hematoma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000601:surgery / Q000628:therapy*; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000627:therapeutic use; D008096:Lithotripsy / Q000009:adverse effects*; D008297:Male; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011860:Radiography, Abdominal; D012187:Retroperitoneal Space; D012307:Risk Factors; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D000890:Anti-Infective Agents; D011480:Protease Inhibitors; D015377:Cilastatin; D015378:Imipenem